Christianson Mark's Form 4 filing
Neuroone Medical Technologies Corp (NMTC) · filed Sep 9, 2025
- Accession no.
- 0001709738-25-000010
- Filed
- Sep 9, 2025
- Trade date
- Sep 5, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $22.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Christianson MarkCIK 0001709738 | Officer (Business Development Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | Common Stock | SSaleDisposed | −30,000 | $0.74F1 | −$22,200 | 231,238 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.7400 to $0.7518 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.